Cargando…
Tumorigenicity of RTK/RAS in urothelium
Autores principales: | Wu, Xue-Ru, Mendelsohn, Cathy, DeGraff, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606002/ https://www.ncbi.nlm.nih.gov/pubmed/26501074 |
Ejemplares similares
-
RTK-RAS pathway mutation is enriched in myeloid sarcoma
por: Choi, Mihong, et al.
Publicado: (2018) -
Spotlight on Accessory Proteins: RTK-RAS-MAPK Modulators as New Therapeutic Targets
por: Pudewell, Silke, et al.
Publicado: (2021) -
Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma
por: Yin, Xiang-Qian, et al.
Publicado: (2022) -
Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
por: Carrot-Zhang, Jian, et al.
Publicado: (2021) -
Whole-genome characterization of lung adenocarcinomas lacking
alterations in the RTK/RAS/RAF pathway
por: Carrot-Zhang, Jian, et al.
Publicado: (2021)